Clinical Trial Update: Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study [Phase 2]

View source ↗

Summary

Phase 2 multicentre randomized trial evaluating everolimus for immunosuppression in de novo liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis
• Liver Failure

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Azienda Ospedaliera di Padova | Conditions: Liver Failure, Liver Diseases | Phase 2 | Status: UNKNOWN